[1]
M.Y. Awad, M. and Younis, A.M. 2023. Empagliflozin alleviates diabetic nephropathy in albino rats through its antioxidative and anti-inflammatory action. Jordan Journal of Applied Science - Natural Science Series. 17, 1 (Jun. 2023), 33-37. DOI:https://doi.org/10.35192/jjoas-n.v17i1.1813.